Almost two years ago, a story appeared on the website www.lowellsun.com which reported on how a start-up company had recently moved it’s headquarters to Littleton in Massachusetts. The company in question focussed on developing storage technology for baby teeth, which had been identified a decade earlier as containing a viable concentration of stem cells, to enable the stem cells to be safely stored for future use in medicine personalized to the owner of the tooth – Alzheimer’s, Parkinson’s, Diabetes and Cancer had been cited as illness that could be treated with future stem cell-related medicine.
Today, the company – Provia Labs – and their Store-A-Tooth dental stem cell storage technology have seen meteoric growth in the number of customers enrolling for the use of their innovative technology, whilst the wider medical research world has embraced stem cell research in a way that no one could have imagined those two short years ago. Stem cell research has become a multi-billion dollar industry in the US and is starting to gain traction in other markets such as Europe, Russia and other CIS countries such as Kazakhstan.
Scott Wolf, Grace Century?s CEO commented “This was one of the first stories covering our portfolio project Store-a-tooth. What a difference just under two years make”
